Guest guest Posted May 9, 2008 Report Share Posted May 9, 2008 I was with my oncologist yesterday and briefly, here is some of what he updated me on: * There is only one active vaccine being worked on, and it showed promise, but the company that pioneered it is not moving very quickly on it. * There are two drugs being developed that both show promise but they will be tough to get through FDA. One by Wyatt, Basatanib is not being heavily pursued because it is a third line drug and both Sprycel and Tasigna have been so well accepted. * They are beginning studies on lower doses of Tasgina starting with 600 mg per day, and the goal is to later test at 400 mg if the 600 mg study shows promise. * There have been great strides made in finding the cell mechanisms that begin the process of CML and it is early, but they are learning great amounts about why certain cells remain " resistant " while others respond to treatment. Forgive me if I have confused any of my details, but this is the best that I can remember. Next time, I must remember to take a tape recorder with me. With warm regards, Matt ville, FL DX January 2005 Gleevec March 2005 Tasigna November 2008 **************Wondering what's for Dinner Tonight? Get new twists on family favorites at AOL Food. (http://food.aol.com/dinner-tonight?NCID=aolfod00030000000001) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.